ReachMD Be part of the knowledge.™

Neurology and Neurosurgery

3933

LikeLikedUnlike

Episodes 1-15 of 127

Case Concepts in Generalized Myasthenia Gravis: Balancing the Need for Glucocorticoids and Integrating FcRn Inhibitors Into Treatment Plans
CME/CE
Case Concepts in Generalized Myasthenia Gravis: Balancing the Need for Glucocorticoids and Integrating FcRn Inhibitors Into Treatment Plans
- Michael Erdman, PharmD, BCCCP
  Peer
- Ali A. Habib, MD
  Peer
1.00 credits
Breaking Ground: The Latest Data on AD Disease-Modifying Therapies
MinuteCE®
Breaking Ground: The Latest Data on AD Disease-Modifying Therapies
- Professor Sir John Hardy
  Peer
1.00 program credits
Precision Imaging: MRI's Critical Role in Early MCI AD Diagnosis
MinuteCE®
Precision Imaging: MRI's Critical Role in Early MCI AD Diagnosis
- Marwan Noel Sabbagh, MD, FAAN, FANA
  Peer
1.00 program credits
Comparative Efficacy: SubQ vs. Intravenous DMTs in Alzheimer's Disease
MinuteCE®
Comparative Efficacy: SubQ vs. Intravenous DMTs in Alzheimer's Disease
- Marwan Noel Sabbagh, MD, FAAN, FANA
  Peer
1.00 program credits
Markers of Memory: Pathological Biomarkers of Clinical MCI Due to AD
MinuteCE®
Markers of Memory: Pathological Biomarkers of Clinical MCI Due to AD
- Marwan Noel Sabbagh, MD, FAAN, FANA
  Peer
1.00 program credits
Inequity and Illness: Understanding MCI Disease Course and Severity for Racial Minorities
MinuteCE®
Inequity and Illness: Understanding MCI Disease Course and Severity for Racial Minorities
- Marwan Noel Sabbagh, MD, FAAN, FANA
  Peer
1.00 program credits
Dementia on a Spectrum: Preclinical Stages of MCI in AD
MinuteCE®
Dementia on a Spectrum: Preclinical Stages of MCI in AD
- Professor Sir John Hardy
  Peer
1.00 program credits
Future Frontiers: The Future Landscape of Alzheimer's Therapeutics
MinuteCE®
Future Frontiers: The Future Landscape of Alzheimer's Therapeutics
- Professor Sir John Hardy
  Peer
1.00 program credits
MinuteCE®
Early Recognition + Earlier Intervention = Slowing the Progression in Mild Cognitive Impairment / Early Alzheimer’s
- Marwan Noel Sabbagh, MD, FAAN, FANA
  Peer
- Professor Sir John Hardy
  Peer
1.00 credits 10 episodes
Therapeutic Insights: Navigating the Use and Challenges of Disease-Modifying Therapies
MinuteCE®
Therapeutic Insights: Navigating the Use and Challenges of Disease-Modifying Therapies
- Professor Sir John Hardy
  Peer
1.00 program credits
Beyond Guesswork: Validated Methods for MCI Assessment in Alzheimer's Diagnosis
MinuteCE®
Beyond Guesswork: Validated Methods for MCI Assessment in Alzheimer's Diagnosis
- Professor Sir John Hardy
  Peer
1.00 program credits
The Subtle Onset: Understanding Early MCI AD Symptoms
MinuteCE®
The Subtle Onset: Understanding Early MCI AD Symptoms
- Marwan Noel Sabbagh, MD, FAAN, FANA
  Peer
1.00 program credits
Exploring Autophagy through Sigma-1 Receptor Activation: Innovative Therapeutics for Alzheimer's Disease Beyond Amyloid Pathways
CME/CE
Exploring Autophagy through Sigma-1 Receptor Activation: Innovative Therapeutics for Alzheimer's Disease Beyond Amyloid Pathways
- Marwan Noel Sabbagh, MD, FAAN, FANA
  Peer
Spinal Muscular Atrophy: Optimizing the Management of Adults in the Era of Disease-Modifying Therapies
CME/CE
Spinal Muscular Atrophy: Optimizing the Management of Adults in the Era of Disease-Modifying Therapies
- Perry Shieh, MD, PhD
  Peer
1.00 credits
Optimizing Your Pharmacologic Approach to Reversing Anticoagulation for ICH
MinuteCE®
Optimizing Your Pharmacologic Approach to Reversing Anticoagulation for ICH
- David Seiffge, MD
  Peer
- Natalie Kreitzer, MD, MS
  Peer
- W. Brian Gibler, MD, FACEP, FACC, FAHA
  Peer
1.50 program credits

Program Chapters

Segment Chapters

Playlist:

Recommended